Key result
Polish SATMED-Q shows high reliability and validity measuring treatment satisfaction in heart failure, diabetes, and hypertension.
Why the study?
Satisfaction with medicines is crucial for patient experiences impacting adherence and compliance, necessitating validation of a general satisfaction measure in Polish patients.
Cross-Sectional (n=197)
The Polish version of the SATMED-Q is a reliable and valid tool for assessing treatment satisfaction in patients with chronic conditions like diabetes, hypertension, and heart failure.
Validated Polish SATMED-Q enables satisfaction assessment in diabetes and hypertension; leaves open links to adherence in practice.
Background: Satisfaction with medicines is crucial in indicating patient experiences with the treatment which impact medicine adherence and compliance. Aim: The aim of this research was to adopt a general measure of patients’ satisfaction with medicines, the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q), to the Polish language (BMQ-PL). Materials and Methods: A total of 197 patients qualified for the research, with the following diagnoses: type 2 diabetes (n = 42), hypertension (n = 55) and heart failure (n = 100), aged 64.73 (SD = 13.27). The criterion-related validity was determined with the use of a Polish version of the Adherence to Refills and Medications Scale. Confirmatory and exploratory factor analyses were used. Results: The respondents’ mean score was 73.63 (SD = 18.42). Cronbach’s alpha for the entire instrument was 0.847. All items of the questionnaire were found to have a positive item–total correlation. A multifactorial linear regression model showed that a significant (p ˂ 0.05) independent variable increasing the SATMED-Q score for the whole group was educational level (vocational education R = 14.576; secondary education R = 14.055; higher education R = 19.372) and low adherence (R = −1.384) was a decreasing variable. Conclusions: The present findings indicate a high level of reliability and validity of the translated SATMED-Q questionnaire, fully comparable to that of the original. The questionnaire can be used for the assessment of satisfaction with medicines among Polish patients.
No takes yet. Share an insight, caveat, or question.
Świątoniowska-Lonc et al. (2022) conducted a cross-sectional in Type 2 diabetes, hypertension, and heart failure (n=197). Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) Polish version was evaluated on Psychometric properties (reliability and validity) of the SATMED-Q. The Polish version of the SATMED-Q demonstrated high reliability (Cronbach's alpha 0.847) and validity for assessing treatment satisfaction among patients with diabetes, hypertension, and heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: